Impacts of the DPP-4 Inhibitor Saxagliptin and SGLT-2 Inhibitor Dapagliflozin on the Gonads of Diabetic Mice
-
Published:2023-09-29
Issue:10
Volume:11
Page:2674
-
ISSN:2227-9059
-
Container-title:Biomedicines
-
language:en
-
Short-container-title:Biomedicines
Author:
Alshamrani Ali A.1ORCID, Al-Hamamah Mohammed A.1, Albekairi Norah A.1, Attia Mohamed S. M.1, Ahmad Sheikh F.1ORCID, Assiri Mohammed A.1ORCID, Ansari Mushtaq A.1ORCID, Nadeem Ahmed1ORCID, Bakheet Saleh A.1ORCID, Alanazi Wael A.1ORCID, Attia Sabry M.1ORCID
Affiliation:
1. Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia
Abstract
Diabetes mellitus is a metabolic disease that can cause systemic problems, including testicular dysfunction. Several diabetes medications have demonstrated potential adverse effects on the male reproductive system; however, the effects of saxagliptin and dapagliflozin have not been sufficiently examined. This investigation studied the impacts of saxagliptin and dapagliflozin treatments on the gonads in a male mouse model of diabetes. Testicular disturbances were assessed by sperm DNA damage, diakinesis-metaphase I chromosome examination, and spermiogram analysis. Our results showed more sperm DNA damage, more spermatocyte chromosome aberrations, lower sperm motility/count, and more sperm morphological anomalies in diabetic mice than in the control mice. Dapagliflozin significantly restored all examined measures to the control values in diabetic mice, unlike saxagliptin, which exacerbated the reduction in sperm count and motility. Both drugs significantly restored the gonadal redox imbalances in diabetic mice by decreasing reactive oxygen species accumulation and increasing glutathione levels. In conclusion, our study presents preliminary evidence for the safety and efficacy of dapagliflozin in alleviating testicular abnormalities induced by diabetes, making it a promising candidate drug for patients with diabetes in their reproductive age. As saxagliptin may have negative effects on fertility, its prescription should be avoided in young male diabetic patients.
Funder
Deputyship for Research and Innovation, “Ministry of Education” in Saudi Arabia
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference47 articles.
1. Hypogonadotropic Hypogonadism in Men with Diabesity;Dhindsa;Diabetes Care,2018 2. Diabetes-induced hyperglycemia impairs male reproductive function: A systematic review;Maresch;Hum. Reprod. Update,2018 3. Feingold, K.R., Anawalt, B., Blackman, M.R., Boyce, A., Chrousos, G., Corpas, E., de Herder, W.W., Dhatariya, K., Dungan, K., and Hofland, J. (2000). Endotext, MDText. 4. Diabetes Mellitus and Infertility: Different Pathophysiological Effects in Type 1 and Type 2 on Sperm Function;Condorelli;Front. Endocrinol.,2018 5. Diabetes Mellitus Causes Male Reproductive Dysfunction: A Review of the Evidence and Mechanisms;He;In Vivo,2021
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|